/Investor DB

T. Rowe Price — 2024 Investments

6 investments dated 2024 · listed companies and verified rows first · show all

Bluejaytxbluejaytx.comMay 2024 · $182Macquired by Mirum Pharmaceuticals · Dec 2025 · $620M

Bluejay is a biotechnology company focused on therapeutic development.

BiotechSan Mateo, US

Keting Chu(Founder, Chief Executive Officer and Chairman of the Board)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFrazier Life SciencesRA CapitalRiverVest Venture PartnersWellington ManagementFrazier Healthcare PartnersHBM Healthcare Investments+2 more

Lambda Labslambda.aiin𝕏Apr 2024 · $320M

Lambda operates cloud infrastructure and supercomputers purpose-built for AI training and inference, serving hyperscalers, enterprises, and frontier AI labs.

AI & Machine LearningCloud ComputingData & InfrastructureSan Francisco, US

Stephen Balaban(Founder)inBenhamin Nelson(Executive Officer)Austen Allred(Executive Officer, Director)ML engineers in(Founder)Michael Balaban(Founder)

BoardJessica Verrilli(Director)

Co-investorsAccess Ventures (New York)Air Street CapitalAlpha Square GroupAlumni VenturesB Capital GroupB4 Capital+37 more

Lilac Solutionslilacsolutions.cominFeb 2024

Lilac Solutions develops direct lithium extraction technology using ceramic ion exchange media, enabling fast, clean, and affordable lithium production from brines for the electric vehicle and battery industries.

CleantechClimate TechEnergyNew MaterialsOakland, US

David Snydacker(Founder)inNicholas Goldberg(Chief Legal Officer of Issuer)David Gelinas(Chief Financial Officer of Issuer)inRaef Sully(Chief Executive Officer of Issuer)inDave Snydacker(Founder)

BoardClay Dumas(Director)in

Co-investorsBreakthrough Energy VenturesLowercarbon CapitalAzolla VenturesBerkeley Angel NetworkBMW i VenturesE8 Angels+10 more

nChroma Bionchromabio.comin𝕏Dec 2024

nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.

BiotechDeep TechMedical DevicesBoston, US

Luke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)David Liu, PhD(Founder)Angelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)Jonathan Weissman, PhD

Co-investorsAtlas VentureNewpath Partners5AM VenturesARCH Venture PartnersDCVC (Data Collective)F-Prime Capital+11 more

Payloadpayloadcms.comin𝕏Apr 2024Acquired

Payload is an open-source Next.js backend platform serving developers and marketers who need flexibility beyond traditional content management systems.

Cloud ComputingDeveloper ToolsEnterprise SoftwareSaaSGrand Rapids, US

James Mikrut(Founder)inElliot DeNolf(Founder)inDan Ribbens(Founder)inRyan Rybolt(Executive Officer, Director)inIan Halpern(Executive Officer, Director)

BoardPatricia Felts(Director)

Co-investorsExceptional CapitalGradient VenturesGrand VenturesY CombinatorAndreessen HorowitzBaillie Gifford+10 more

Seagenseagen.ioFeb 2024 · $112M

SeaGen develops automated robots that monitor aquatic ecosystems and remove pollutants while supporting the growth of beneficial species like seaweed to improve food and water security and reduce atmospheric carbon.

CleantechClimate TechRobotics

Co-investorsAera VCRidgeback CapitalAlly Bridge GroupRA Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.